Literature DB >> 9407167

Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2.

P Wolkenstein1, H Benchikhi, J Zeller, J Wechsler, J Revuz.   

Abstract

BACKGROUND: Schwannomatosis includes multiple cutaneous schwannomas, central nervous system tumors and various neurologic deficits.
OBJECTIVE: To specify the clinical presentation of schwannomatosis, excluding neurofibromatosis type 2 (NF2).
METHODS: Patients with at least 2 cutaneous schwannomas were evaluated for NF2 criteria.
RESULTS: 5 men and 2 women (mean age 54 +/- 18 years) we included. Two cases were familial. Cutaneous schwannomas were tender nodules with onset above the age of 30 years. Four patients had paresthesias. Four patients had hypacusis, but auditory brainstem responses showed no retrocochlear involvement. No vestibular schwannoma or central nervous system tumor was found with magnetic resonance imaging in 6 patients. Spinal imaging performed in 6 patients was normal in 5 and showed a spinal schwannoma in the 6th patient.
CONCLUSION: We strictly eliminated the diagnosis of NF2 in our patients. Exclusion of NF2 in suspected schwannomatosis is essential for further molecular genetic studies.

Entities:  

Mesh:

Year:  1997        PMID: 9407167     DOI: 10.1159/000245948

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

1.  Multiple schwannomas: report of two cases.

Authors:  V K Javalkar; T Pigott; P Pal; G Findlay
Journal:  Eur Spine J       Date:  2007-01-10       Impact factor: 3.134

2.  Aberrant axon neurofilaments in schwannomas associated with phacomatoses.

Authors:  Janine Wechsler; Laurent Lantieri; Jacques Zeller; Marie-Catherine Voisin; Nadine Martin-Garcia; Pierre Wolkenstein
Journal:  Virchows Arch       Date:  2003-09-24       Impact factor: 4.064

3.  [18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis.

Authors:  I Gallais Sérézal; S Ferkal; L Lerman; S Mulé; B Funalot; P Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2021-01-28       Impact factor: 4.123

4.  ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.

Authors:  D Gareth Evans; Stefania Mostaccioli; David Pang; Mary Fadzil O Connor; Melpo Pittara; Nicolas Champollion; Pierre Wolkenstein; Nick Thomas; Rosalie E Ferner; Michel Kalamarides; Matthieu Peyre; Laura Papi; Eric Legius; Juan Luis Becerra; Andrew King; Chris Duff; Stavros Stivaros; Ignacio Blanco
Journal:  Eur J Hum Genet       Date:  2022-04-01       Impact factor: 5.351

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.